Breast cancer
Last updated: 01 November 2019
You can legally access new medicines, even if they are not approved in your country.
Learn more »Lynparza (olaparib) is the first PARP inhibitor approved to treat breast cancer, and the first medicine ever for metastatic breast cancer who have a “BRCA” gene mutation.
Read more